These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4853133)

  • 21. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 22. The elimination of 5-hydroxyindoleacetic acid from cerebrospinal fluid: characteristics of the acid transport system of the choroid plexus.
    Sampath SS; Neff NH
    J Pharmacol Exp Ther; 1974 Feb; 188(2):410-4. PubMed ID: 4359553
    [No Abstract]   [Full Text] [Related]  

  • 23. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK; Post RM
    Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
    [No Abstract]   [Full Text] [Related]  

  • 24. Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid.
    Bowers MB
    Brain Res; 1969 Oct; 15(2):522-4. PubMed ID: 5344382
    [No Abstract]   [Full Text] [Related]  

  • 25. Precursor and end product effects upon indoleamine maturation in mouse brain.
    Hoff KM; Baker PC; Buda RE
    Biol Neonate; 1976; 29(5-6):360-7. PubMed ID: 974194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog.
    Ashcroft GW; Dow RC; Moir AT
    J Physiol; 1968 Dec; 199(2):397-425. PubMed ID: 5723518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma.
    Neef NH; Tozer TN; Brodie BB
    J Pharmacol Exp Ther; 1967 Nov; 158(2):214-8. PubMed ID: 6065144
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of probenecid on the elimination from CSF of intraventricularly injected 5-hydroxyindolecetic acid in normal and hydrocephalic dogs.
    Anderson H; Roos BE
    J Pharm Pharmacol; 1968 Nov; 20(11):879-81. PubMed ID: 4387498
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo measurements by differential pulse voltammetry of extra-cellular 5-hydroxyindoleacetic acid in the rat brain.
    Cespuglio R; Faradji H; Ponchon JL; Riou F; Buda M; Gonon F; Pujol JF; Jouvet M
    J Physiol (Paris); 1981; 77(2-3):327-32. PubMed ID: 6169830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation and elimination of 5-HIAA in developing brain.
    Tissari AH; Raunu EM
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):86. PubMed ID: 5314452
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a probenecid sensitive transport system for monoamine catabolites at the level of the brain capillary plexus?
    Yuwiler A; Bennett BL; Geller E
    Neurochem Res; 1982 Oct; 7(10):1277-85. PubMed ID: 6185860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

  • 33. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 34. Digoxin-induced arrest of the cerebrospinal fluid circulation in the infant rat: implications for medical treatment of hydrocephalus during early postnatal life.
    Bass NH; Fällström SP; Lundborg P
    Pediatr Res; 1979 Jan; 13(1):26-30. PubMed ID: 431998
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of valproic acid on the 5-hydroxyindoleacetic, homovanillic and lactic acid levels of cerebrospinal fluid.
    MacMillan V; Leake J; Chung T; Bovell M
    Brain Res; 1987 Sep; 420(2):268-76. PubMed ID: 2445434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.
    van Praag HM; Korf J; Puite J
    Nature; 1970 Mar; 225(5239):1259-60. PubMed ID: 5435360
    [No Abstract]   [Full Text] [Related]  

  • 37. 5-Hydroxyindoleacetic acid in cerebrospinal fluid.
    Molnár G; Fodor A; Karczag I; Szilágyi A; Ujvárosi I
    Acta Med Acad Sci Hung; 1973; 30(3):211-7. PubMed ID: 4785998
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum tryptophan decreased, brain tryptophan increased and brain serotonin synthesis unchanged after probenecid loading.
    Korf J; Van Praag HM; Sebens JB
    Brain Res; 1972 Jul; 42(1):239-42. PubMed ID: 5047195
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of alpha-adrenolytics on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rat's brain.
    Zebrowska-Lupina I; Kleinrok Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):241-5. PubMed ID: 1713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of probenecid on cerebral and cisternal cerebrospinal fluid lactate content.
    MacMillan V
    J Cereb Blood Flow Metab; 1987 Feb; 7(1):118-23. PubMed ID: 2433297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.